150 related articles for article (PubMed ID: 1571537)
1. Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivo.
Dunlop DJ; Wright EG; Lorimore S; Graham GJ; Holyoake T; Kerr DJ; Wolpe SD; Pragnell IB
Blood; 1992 May; 79(9):2221-5. PubMed ID: 1571537
[TBL] [Abstract][Full Text] [Related]
2. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells.
Eaves CJ; Cashman JD; Wolpe SD; Eaves AC
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):12015-9. PubMed ID: 8265663
[TBL] [Abstract][Full Text] [Related]
3. Suppressive effect of LD78 on the proliferation of human hemopoietic progenitors.
Shiozaki H; Ide T; Nakao J; Imamura T; Nakamura M; Shimada K; Miura Y; Suda T
Jpn J Cancer Res; 1992 May; 83(5):499-504. PubMed ID: 1618701
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta: is it a downregulator of stem cell inhibition by macrophage inflammatory protein 1 alpha?
Maltman J; Pragnell IB; Graham GJ
J Exp Med; 1993 Sep; 178(3):925-32. PubMed ID: 8394405
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation.
Graham GJ; Wright EG; Hewick R; Wolpe SD; Wilkie NM; Donaldson D; Lorimore S; Pragnell IB
Nature; 1990 Mar; 344(6265):442-4. PubMed ID: 2320111
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.
Broxmeyer HE; Sherry B; Cooper S; Lu L; Maze R; Beckmann MP; Cerami A; Ralph P
J Immunol; 1993 Apr; 150(8 Pt 1):3448-58. PubMed ID: 7682242
[TBL] [Abstract][Full Text] [Related]
7. Polymerization of murine macrophage inflammatory protein 1 alpha inactivates its myelosuppressive effects in vitro: the active form is a monomer.
Mantel C; Kim YJ; Cooper S; Kwon B; Broxmeyer HE
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2232-6. PubMed ID: 8460127
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo.
Lord BI; Dexter TM; Clements JM; Hunter MA; Gearing AJ
Blood; 1992 May; 79(10):2605-9. PubMed ID: 1586712
[TBL] [Abstract][Full Text] [Related]
9. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
Verfaillie CM; Miller JS
Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
[TBL] [Abstract][Full Text] [Related]
10. Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth.
Broxmeyer HE; Sherry B; Cooper S; Ruscetti FW; Williams DE; Arosio P; Kwon BS; Cerami A
J Immunol; 1991 Oct; 147(8):2586-94. PubMed ID: 1918979
[TBL] [Abstract][Full Text] [Related]
11. BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical properties.
Hunter MG; Bawden L; Brotherton D; Craig S; Cribbes S; Czaplewski LG; Dexter TM; Drummond AH; Gearing AH; Heyworth CM; Lord BI; McCourt M; Varley PG; Wood LM; Edwards RM; Lewis PJ
Blood; 1995 Dec; 86(12):4400-8. PubMed ID: 8541527
[TBL] [Abstract][Full Text] [Related]
12. Use of 5-fluorouracil to analyze the effect of macrophage inflammatory protein-1 alpha on long-term reconstituting stem cells in vivo.
Quesniaux VF; Graham GJ; Pragnell I; Donaldson D; Wolpe SD; Iscove NN; Fagg B
Blood; 1993 Mar; 81(6):1497-504. PubMed ID: 8453096
[TBL] [Abstract][Full Text] [Related]
13. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
Holyoake TL; Freshney MG; Sproul AM; Richmond LJ; Alcorn MJ; Steward WP; Fitzsimons E; Dunlop DJ; Franklin IM; Pragnell IB
Stem Cells; 1993 Oct; 11 Suppl 3():122-8. PubMed ID: 8298472
[TBL] [Abstract][Full Text] [Related]
14. Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1 alpha.
Cooper S; Mantel C; Broxmeyer HE
Exp Hematol; 1994 Feb; 22(2):186-93. PubMed ID: 8299739
[TBL] [Abstract][Full Text] [Related]
15. The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism.
Cashman JD; Eaves AC; Eaves CJ
Blood; 1994 Sep; 84(5):1534-42. PubMed ID: 8068944
[TBL] [Abstract][Full Text] [Related]
16. Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth.
Keller JR; Bartelmez SH; Sitnicka E; Ruscetti FW; Ortiz M; Gooya JM; Jacobsen SE
Blood; 1994 Oct; 84(7):2175-81. PubMed ID: 7919333
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha.
Ferrajoli A; Talpaz M; Zipf TF; Hirsch-Ginsberg C; Estey E; Wolpe SD; Estrov Z
Leukemia; 1994 May; 8(5):798-805. PubMed ID: 8182937
[TBL] [Abstract][Full Text] [Related]
18. A novel chemokine, macrophage inflammatory protein-related protein-2, inhibits colony formation of bone marrow myeloid progenitors.
Youn BS; Jang IK; Broxmeyer HE; Cooper S; Jenkins NA; Gilbert DJ; Copeland NG; Elick TA; Fraser MJ; Kwon BS
J Immunol; 1995 Sep; 155(5):2661-7. PubMed ID: 7650394
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow-purified CD34+ progenitors.
Bonnet D; Lemoine FM; Najman A; Guigon M
Exp Hematol; 1995 Jun; 23(6):551-6. PubMed ID: 7539383
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
